Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2025-12-25 @ 1:49 PM
NCT ID: NCT02946892
Description: AE were classified as serious or non-serious also related to study drug or unrelated to study drug at the time of the study visit.
Frequency Threshold: 0
Time Frame: 36 weeks
Study: NCT02946892
Study Brief: Effect of Carvedilol on Exercise Performance in Fontan Patients
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Carvedilol Study participants will receive carvedilol for 12 weeks Carvedilol: Carvedilol will be given for 12 weeks and then an exercise test will be performed 0 None 0 25 4 25 View
Placebo Study participants will receive placebo (sugar pill) for 12 weeks Placebo: Placebo will be given for 12 weeks and then an exercise test will be performed 0 None 0 24 0 24 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Bradycardia SYSTEMATIC_ASSESSMENT Cardiac disorders None View